Potential drug interactions among cancer patients using oral cytostatic drugs: a prevalence study

Potential drug interactions among cancer patients using oral cytostatic drugs: a multicenter cross-sectional study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN01739090

Enrollment

1000

Registered

2012-02-20

Start date

2012-01-01

Completion date

Unknown

Last updated

2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Cancer

Interventions

To identify the patients a search is conducted in the computer based medication prescription system of the outpatients hospital pharmacy for delivery of oral anticancer drugs in the previous 12 months

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All ambulatory patients with the diagnosis solid tumour or a malignant haematological disease who are receiving oral anticancer therapy

Exclusion criteria

Exclusion criteria: 1. The use of experimental trial agents 2. Age <18 years 3. The use of oral anticancer drugs for non-oncological diseases

Design outcomes

Primary

Measure	Time frame
To investigate the prevalence of DDIs among ambulatory cancer patients on oral anticancer treatment	—

Secondary

Measure	Time frame
To gain more insight into possible determinants for the occurrence of these DDIs	—

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026